Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.180
-0.050 (-1.18%)
Jul 21, 2026, 1:43 PM EDT - Market open
Treace Medical Concepts Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.54 | 10.71 | 11.35 | 12.98 | 19.47 | 105.83 |
Short-Term Investments | 42.31 | 37.66 | 64.33 | 110.22 | 61.78 | - |
Cash & Short-Term Investments | 51.85 | 48.37 | 75.68 | 123.2 | 81.25 | 105.83 |
Cash Growth | -31.85% | -36.09% | -38.57% | 51.63% | -23.23% | 485.39% |
Accounts Receivable | 30.36 | 42.16 | 40.8 | 38.06 | 29.2 | 18.57 |
Inventory | 36.37 | 36.03 | 39.26 | 29.25 | 19.33 | 10.56 |
Other Current Assets | 4.89 | 5.5 | 5.67 | 7.85 | 3.62 | 3.01 |
Total Current Assets | 123.47 | 132.05 | 161.4 | 198.36 | 133.4 | 137.97 |
Net Property, Plant & Equipment | 39.43 | 37.37 | 34.4 | 31.56 | 25.48 | 2.85 |
Other Intangible Assets | 6.89 | 7.13 | 8.08 | 9.03 | - | - |
Goodwill | 12.82 | 12.82 | 12.82 | 12.82 | - | - |
Other Long-Term Assets | 1.5 | 1.22 | 0.41 | 0.15 | 0.15 | - |
Total Assets | 184.1 | 190.58 | 217.09 | 251.91 | 159.02 | 140.82 |
Accounts Payable | 13.54 | 6.73 | 10.52 | 11.84 | 8.67 | 4.06 |
Accrued Expenses | 18.35 | 21.48 | 23.89 | 28.77 | 21.24 | 14.15 |
Other Current Liabilities | 2.6 | 2.43 | 0.51 | 4.43 | 0.34 | - |
Total Current Liabilities | 34.49 | 30.64 | 34.93 | 45.03 | 30.25 | 18.21 |
Long-Term Debt | 55.82 | 55.58 | 53.31 | 53.01 | 52.71 | 29.37 |
Long-Term Leases | 13.55 | 13.98 | 15.93 | 15.89 | 15.54 | - |
Other Long-Term Liabilities | 3.05 | 3.05 | 0.04 | 0.04 | - | 0.17 |
Total Long-Term Liabilities | 72.42 | 72.61 | 69.28 | 68.94 | 68.25 | 29.54 |
Total Liabilities | 106.91 | 103.25 | 104.2 | 113.97 | 98.5 | 47.75 |
Common Stock | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
Treasury Stock | -1.39 | -1.18 | -0.28 | -0.01 | - | - |
Additional Paid-in Capital | 345.5 | 337.37 | 303 | 271.97 | 145.22 | 134.93 |
Accumulated Other Comprehensive Income | -0.03 | 0.07 | 0.1 | 0.16 | -0.03 | - |
Retained Earnings | -266.95 | -248.99 | -189.99 | -134.25 | -84.72 | -41.91 |
Shareholders' Equity | 77.19 | 87.33 | 112.89 | 137.94 | 60.53 | 93.07 |
Total Liabilities & Equity | 184.1 | 190.58 | 217.09 | 251.91 | 159.02 | 140.82 |
Total Debt | 69.37 | 69.57 | 69.24 | 68.9 | 68.25 | 29.37 |
Net Cash (Debt) | -17.52 | -21.2 | 6.44 | 54.3 | 13 | 76.47 |
Net Cash Growth | - | - | -88.14% | 317.62% | -83.00% | - |
Net Cash Per Share | -0.28 | -0.34 | 0.10 | 0.89 | 0.23 | 1.58 |
Book Value | 77.19 | 87.33 | 112.89 | 137.94 | 60.53 | 93.07 |
Book Value Per Share | 1.21 | 1.38 | 1.82 | 2.27 | 1.10 | 1.92 |
Tangible Book Value | 57.49 | 67.39 | 92 | 116.1 | 60.53 | 93.07 |
Tangible Book Value Per Share | 0.90 | 1.07 | 1.48 | 1.91 | 1.10 | 1.92 |